The Economic Times daily newspaper is available online now.

    Azim Premji takes covid vaccine as govt steps up vaccination drive

    Synopsis

    Prominent business personalities, from Infosys’ NR Narayana Murthy to Biocon’s Kiran Mazumdar-Shaw, have participated in the second phase of India’s covid vaccination drive.

    Azim Premji 2
    Azim Premji, founder chairman of Wipro Ltd.
    Bengaluru: Azim Premji, founder chairman of Wipro Ltd., took the Covid-19 vaccine shot at the Narayana Health City in Bengaluru on Tuesday. He is one among renowned personalities to have taken the jab, with the government stepping up the drive to get more people vaccinated against the coronavirus in the second phase.

    The hospital authorities did not offer any comment.

    Elevate Your Tech Prowess with High-Value Skill Courses

    Offering CollegeCourseWebsite
    IIM LucknowIIML Executive Programme in FinTech, Banking & Applied Risk ManagementVisit
    MITMIT Technology Leadership and InnovationVisit
    IIT DelhiIITD Certificate Programme in Data Science & Machine LearningVisit
    On Monday, the first day of the second phase of vaccination in India, Infosys co-founder N.R. Narayana Murthy, his wife Sudha Murty, Infosys co-founder Kris Gopalakrishnan and Biocon Ltd.’s founder and executive chairperson, Kiran Mazumdar-Shaw, took the jab at Narayana Hrudayalaya in Bengaluru.

    While Murthy told ET that the process went off well and they felt very nice at the end of it, Mazumdar-Shaw tweeted that the covid vaccination process was painless and without any side-effects.

    “I guess it’s a booster dose for me since I had Covid 6 months ago. Feel safe & protected,” she said. She also urged eligible citizens to get themselves vaccinated.

    https://twitter.com/kiranshaw/status/1366314290307887104

    Last month, Premji requested the government to immediately allow private participation in the country’s vaccination drive against Covid-19 and stated that more than 500 million people can be vaccinated in 60 days with the involvement of private firms and institutions.
    The Economic Times

    Stories you might be interested in